24 HR Minocycline 115 MG Extended Release Oral Tablet
1 INDICATIONS & USAGE Minocycline hydrochloride extended-release tablets is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. 1.1 Indication Minocycline hydrochloride extended-release tablets is indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. 1.2 Limitations of Use Minocycline hydrochloride extended-release tablets did not demonstrate any effect on non-inflammatory acne lesions. Safety of Minocycline hydrochloride extended-release tablets has not been established beyond 12 weeks of use. This formulation of minocycline has not been evaluated in the treatment of infections [see Clinical Studies (14) ] . To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, Minocycline hydrochloride extended-release tablets should be used only as indicated [see Warnings and Precautions (5.11) ] .
ascend laboratories, llc
Related Pills
Methocarbamol 750 MG Oral Tablet
KAISER FOUNDATION HOSPITALS
Methocarbamol 750 MG Oral Tablet
REMEDYREPACK INC.
Methocarbamol Methocarbamol 750 MG Oral Tablet
Preferred Pharmaceuticals, Inc.
Hyoscyamine Sulfate 12 HR Hyoscyamine Sulfate 0.375 MG Extended Release Oral Tablet
Franklin Pharmaceutical LLC
Methocarbamol Methocarbamol 750 MG Oral Tablet
Preferred Pharmaceuticals, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
MINOCYCLINE HYDROCHLORIDE extended-release tablets, USP are supplied as aqueous film coated tablets containing
MINOCYCLINE HYDROCHLORIDE equivalent to 45 mg, 55 mg, 65 mg, 80 mg, 90 mg, 105 mg, 115 mg or 135 mg minocycline, are supplied as follows. The 45 mg extended release tablets are grey coloured capsule shaped film coated tablets, debossed with “45” on one side, plain on other side. Each tablet contains
MINOCYCLINE HYDROCHLORIDE equivalent to 45 mg minocycline, supplied as follows: NDC 67877-578-14 Carton of 140 (10 x 14 unit-dose) NDC 67877-578-30 Bottle of 30 NDC 67877-578-01 Bottle of 100 NDC 67877-578-05 Bottle of 500 The 55 mg extended release tablets are pink colored capsule shaped film coated tablets, debossed with "55" on one side, plain on other side. Each tablet contains
MINOCYCLINE HYDROCHLORIDE equivalent to 55 mg minocycline, supplied as follows: NDC 67877-436-14 Carton of 140 (10 x 14 unit-dose) NDC 67877-436-30 Bottle of 30 NDC 67877-436-01 Bottle of 100 NDC 67877-436-05 Bottle of 500 The 65 mg extended release tablets are blue coloured capsule shaped film coated tablets, debossed with “65” on one side, plain on other side. Each tablet contains
MINOCYCLINE HYDROCHLORIDE equivalent to 65 mg minocycline, supplied as follows: NDC 67877-643-14 Carton of 140 (10 x 14 unit-dose) NDC 67877-643-30 Bottle of 30 NDC 67877-643-01 Bottle of 100 NDC 67877-643-05 Bottle of 500 The 80 mg extended release tablets are greyish brown colored capsule shaped film coated tablets, debossed with "80'' on one side, plain on other side. Each tablet contains
MINOCYCLINE HYDROCHLORIDE equivalent to 80 mg minocycline, supplied as follows: NDC 67877-437-14 Carton of 140 (10 x 14 unit-dose) NDC 67877-437-30 Bottle of 30 NDC 67877-437-01 Bottle of 100 NDC 67877-437-05 Bottle of 500 The 90 mg extended release tablets are yellow coloured capsule shaped film coated tablets, debossed with “90” on one side, plain on other side. Each tablet contains
MINOCYCLINE HYDROCHLORIDE equivalent to 90 mg minocycline, supplied as follows: NDC 67877-576-14 Carton of 140 (10 x 14 unit-dose) NDC 67877-576-30 Bottle of 30 NDC 67877-576-01 Bottle of 100 NDC 67877-576-05 Bottle of 500 The 105 mg extended release tablets are purple colored capsule shaped film coated tablets, debossed with "105'' on one side, plain on other side.Each tablet contains
MINOCYCLINE HYDROCHLORIDE equivalent to 105 mg minocycline, supplied as follows: NDC 67877-438-14 Carton of 140 (10 x 14 unit-dose) NDC 67877-438-30 Bottle of 30 NDC 67877-438-01 Bottle of 100 NDC 67877-438-05 Bottle of 500 The 115 mg extended release tablets are green coloured capsule shaped film coated tablets, debossed with “115” on one side, plain on other side. Each tablet contains
MINOCYCLINE HYDROCHLORIDE equivalent to 115 mg minocycline, supplied as follows: NDC 67877-644-14 Carton of 140 (10 x 14 unit-dose) NDC 67877-644-30 Bottle of 30 NDC 67877-644-01 Bottle of 100 NDC 67877-644-05 Bottle of 500 The 135 mg extended release tablets are pink (orange brown) coloured capsule shaped film coated tablets, debossed with “135” on one side, plain on other side. Each tablet contains
MINOCYCLINE HYDROCHLORIDE equivalent to 135 mg minocycline, supplied as follows: NDC 67877-577-14 Carton of 140 (10 x 14 unit-dose) NDC 67877-577-30 Bottle of 30 NDC 67877-577-01 Bottle of 100 NDC 67877-577 -05 Bottle of 500 16.2 Storage Store at 20˚ to 25˚C (68˚ to 77˚ F) [See USP Controlled Room Temperature]. 16.3 Handling Keep out of reach of children. Protect from light, moisture, and excessive heat. Dispense in tight, light-resistant container with child-resistant closure.
More pills like CAPSULE 115